Verition Fund Management LLC Sells 27,043 Shares of DocGo Inc. (NASDAQ:DCGO)

Verition Fund Management LLC trimmed its stake in shares of DocGo Inc. (NASDAQ:DCGO) by 46.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,530 shares of the company’s stock after selling 27,043 shares during the quarter. Verition Fund Management LLC’s holdings in DocGo were worth $105,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of DCGO. Deerfield Management Company L.P. Series C increased its position in DocGo by 41.0% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock valued at $22,236,000 after purchasing an additional 2,091,569 shares during the period. WCM Investment Management LLC increased its position in shares of DocGo by 0.6% during the third quarter. WCM Investment Management LLC now owns 2,626,971 shares of the company’s stock valued at $8,879,000 after buying an additional 15,933 shares during the period. P.A.W. Capital Corp raised its stake in DocGo by 1.9% in the third quarter. P.A.W. Capital Corp now owns 1,630,000 shares of the company’s stock worth $5,412,000 after buying an additional 30,000 shares in the last quarter. Harbor Capital Advisors Inc. boosted its position in DocGo by 144.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 968,537 shares of the company’s stock valued at $3,216,000 after acquiring an additional 572,522 shares in the last quarter. Finally, Isthmus Partners LLC grew its holdings in shares of DocGo by 32.4% during the 2nd quarter. Isthmus Partners LLC now owns 799,296 shares of the company’s stock worth $25,000 after acquiring an additional 195,428 shares during the period. 56.44% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Cantor Fitzgerald restated an “overweight” rating and set a $5.00 target price on shares of DocGo in a report on Friday, September 20th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, DocGo presently has an average rating of “Buy” and a consensus price target of $6.10.

DocGo Price Performance

NASDAQ DCGO opened at $4.49 on Tuesday. DocGo Inc. has a 1-year low of $2.75 and a 1-year high of $5.70. The business has a 50 day simple moving average of $3.83 and a two-hundred day simple moving average of $3.50. The stock has a market capitalization of $458.21 million, a PE ratio of 16.04, a P/E/G ratio of 3.81 and a beta of 0.98.

Insider Activity at DocGo

In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the transaction, the general counsel now directly owns 175,645 shares in the company, valued at $779,863.80. This trade represents a 11.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 2.70% of the stock is currently owned by insiders.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.